The Kinetics of β‐Hematin Crystallization Measured by Depolarized Light Scattering
Source abstract
Abstract
Abstract Malaria is caused by Plasmodium sp. parasites transmitted by infected female Anopheles sp. mosquitoes. The survival of the parasites in the host relies on detoxifying free heme by biocrystallization into insoluble crystals called hemozoin. This mechanism of self‐preservation is targeted by a certain class of antimalarial drugs, which are screened and selected based on their capacity to inhibit the formation of hemozoin crystals. Therefore, experimental techniques capable of accurately characterizing the kinetics of crystal formation are valuable. Relying on the optical anisotropy of hemozoin, the kinetics of β‐hematin crystal formation through the statistical analysis of photon counts of dynamic depolarized light scattering (DDLS), in the absence and presence of an antimalarial drug (chloroquine, CQ), is described. It is found that CQ has an impact on both the nucleation and growth of the crystals.
Source: crossref · Quality: baseline
Research context
OpenAlex topics: Crystallization and Solubility Studies · Enzyme Structure and Function · Computational Drug Discovery Methods
SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.
Affiliations
Adolphe Merkle Institute University of Fribourg, Chemin des Verdiers 4,1700 Fribourg Switzerland
Funding
Adolphe Merkle Foundation · Université de Fribourg
References (35)
Show source-provided references
1. 10.1016/S0140-6736(12)60034-810.1016/S0140-6736(12)60034-8 ↗
2. Sullivan D. J. · 2005
3. 10.1016/j.bbagen.2014.02.00910.1016/j.bbagen.2014.02.009 ↗
4. 10.1146/annurev-micro-091313-10353710.1146/annurev-micro-091313-103537 ↗
5. 10.1021/cr078274t10.1021/cr078274t ↗
6. 10.1016/j.ijantimicag.2012.12.00710.1016/j.ijantimicag.2012.12.007 ↗
7. 10.1172/JCI2168210.1172/JCI21682 ↗
8. Sinha S. · Front. Pharmacol. · 2017 · 8
9. 10.1038/nrd141610.1038/nrd1416 ↗
10. 10.1021/ja308741e10.1021/ja308741e ↗
11. 10.1038/3500513210.1038/35005132 ↗
12. 10.1016/S0731-7085(99)00021-710.1016/S0731-7085(99)00021-7 ↗
13. 10.1021/acs.jpcb.7b0497110.1021/acs.jpcb.7b04971 ↗
14. 10.1021/acs.analchem.7b0490810.1021/acs.analchem.7b04908 ↗
15. Goodman J. W. · 2000
16. 10.1007/978-1-4613-2389-110.1007/978-1-4613-2389-1 ↗
17. 10.1073/pnas.88.2.32510.1073/pnas.88.2.325 ↗
18. 10.1016/S0166-6851(00)00365-010.1016/S0166-6851(00)00365-0 ↗
19. 10.1021/ja067418310.1021/ja0674183 ↗
20. 10.1364/AO.18.00096210.1364/AO.18.000962 ↗
21. 10.1073/pnas.93.21.1186510.1073/pnas.93.21.11865 ↗
22. 10.1073/pnas.150102311210.1073/pnas.1501023112 ↗
23. 10.1021/acs.cgd.5b0115710.1021/acs.cgd.5b01157 ↗
24. 10.1021/cg070427i10.1021/cg070427i ↗
25. 10.1021/cg025550i10.1021/cg025550i ↗
26. 10.1021/acs.langmuir.7b0113210.1021/acs.langmuir.7b01132 ↗
27. 10.1038/202805a010.1038/202805a0 ↗
28. 10.1021/bi00549a60010.1021/bi00549a600 ↗
29. 10.1016/j.jinorgbio.2005.11.00510.1016/j.jinorgbio.2005.11.005 ↗
30. 10.1039/b906514h10.1039/b906514h ↗
31. 10.1063/1.275556910.1063/1.2755569 ↗
32. 10.1039/C7LC00758B10.1039/C7LC00758B ↗
33. 10.1016/j.ijpddr.2014.08.00210.1016/j.ijpddr.2014.08.002 ↗
34. 10.1364/AO.34.00354610.1364/AO.34.003546 ↗
35. 10.1042/bj346024910.1042/bj3460249 ↗